Robert Andrew Falconer,Jason Gill,Jennifer Xavier,Paul Loadman,Michael Bibby,Laurence Patterson
申请号：
US16946391
公开号：
US20200316212A1
申请日:
2020.06.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
